Comprehensive immunoprofiling of peripheral blood
US-2024177803-A1 · May 30, 2024 · US
US9920370B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9920370-B2 |
| Application number | US-201514696278-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 24, 2015 |
| Priority date | Jan 22, 2013 |
| Publication date | Mar 20, 2018 |
| Grant date | Mar 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods are provided to determine the entire genomic region of a particular HLA locus including both intron and exons. The resultant consensus sequences provides linkage information between different exons, and produces the unique sequence from each of the two genes from the individual sample being typed. The sequence information in intron regions along with the exon sequences provides an accurate HLA haplotype.
Opening claim text (preview).
What is claimed is: 1. A method for determining a haplotype of an HLA locus, the method comprising: amplifying an HLA gene to produce an amplified HLA gene from a sample comprising a source of genomic DNA and having a genotype, wherein said amplifying step comprises performing a long-range polymerase chain reaction (PCR); and wherein the amplified HLA gene is fragmented to produce a fragmented amplified HLA gene and ligated to barcode primers comprising: (i) a target specific identifier for the source of the genomic DNA; (ii) a target specific identifier for the HLA gene; and (iii) a sequencing adaptor; sequencing the amplified HLA gene to produce a plurality of sequences; and performing deconvolution analysis to resolve the haplotype of the locus, wherein deconvolution analysis comprises the steps of: (a) mapping the plurality of sequences to a reference chromatid generating a tiling pattern, wherein a continuous tiling pattern indicates a correct mapping of the sequences to the reference chromatid and a staggered tiling pattern indicates an incorrect mapping of the sequences to a reference chromatid; (b) filtering out reference chromatids with incorrect mapping; and (c) assigning the reference chromatid with a correct mapping as the haplotype of the locus. 2. The method of claim 1 , wherein the HLA locus is an HLA Class I locus. 3. The method of claim 1 , wherein the fragmented amplified HLA gene is sequenced to a depth of at least 100 reads per sequence. 4. The method of claim 1 , wherein the fragmented amplified HLA gene is sequenced to a depth of at least 1000 reads per sequence. 5. The method of claim 4 , wherein the at least 1000 reads per sequence are mapped to a reference chromatid. 6. The method of claim 5 , wherein the step of mapping to a reference chromatid comprises the steps of: counting a number of “central reads” for any given point, where central reads are empirically defined as mapped reads for which a ratio between a length of a left arm and that of a right arm related to a particular point is between 0.5 and 2; computing the minimum coverage of overall reads (MOOR) and the minimum coverage of central reads (MCCR) for each reference; eliminating references with an MOOR less than 20 and an MCCR less than 10; enumerating all possible combinations of either one reference (homozygous allele) or two references (heterozygous alleles) of the same locus from the remaining references; counting a number of distinct reads that map to each combination; wherein the combination with a maximum number of distinct reads is assigned as the genotype of that sample. 7. The method of claim 1 , wherein the amplified HLA gene comprises at least two exons and at least two introns.
Polymorphic or mutational markers · CPC title
Haplotypes · CPC title
for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes · CPC title
Prognosis of disease development · CPC title
Physics · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.